Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Cuneo

Showing results (51-60 of 185) with videos related to

Pageof 19
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2005
A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytesGiulio Cabrini, Simonetta Falzoni, Sylvia L Forchap, et al.
BMC Research Notes|November 19, 2013
Delirium in acute promyelocytic leukemia patients: two case reportsGian Matteo Rigolin, Sara Martinelli, Luca Formigaro, et al.
Blood|January 28, 2006
Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL)Paola Secchiero, Elisa Barbarotto, Mario Tiribelli, et al.
Molecular Cancer|May 28, 2010
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemiaManuela Ferracin, Barbara Zagatti, Lara Rizzotto, et al.
British Journal of Haematology|March 22, 2003
Soluble urokinase-type plasminogen activator receptor (suPAR) as an independent factor predicting worse prognosis and extra-bone marrow involvement in multiple myeloma patientsGian Matteo Rigolin, Alessia Tieghi, Maria Ciccone, et al.
Leukemia Research|July 27, 2014
Appropriate use of bendamustine in first-line therapy of chronic lymphocytic leukemia. Recommendations from SIE, SIES, GITMO GroupAntonio Cuneo, Monia Marchetti, Giovanni Barosi, et al.
Oncotarget|January 15, 2015
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemiasEmmanouil Athanasakis, Elisabetta Melloni, Gian Matteo Rigolin, et al.
Leukemia Research|September 3, 2011
SIE, SIES, GITMO updated clinical recommendations for the management of chronic lymphocytic leukemiaFrancesca Romana Mauro, Giuseppe Bandini, Giovanni Barosi, et al.
British Journal of Haematology|August 4, 2004
In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34 cellsGian Matteo Rigolin, Matteo Della Porta, Maria Ciccone, et al.
Plos One|September 9, 2016
The Active Metabolite of Warfarin (3'-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics StudyDonato Gemmati, Francesco Burini, Anna Talarico, et al.
Pageof 19

Showing results (51-60 of 185) with videos related to

Sort By:
Pageof 19
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2005
A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytesGiulio Cabrini, Simonetta Falzoni, Sylvia L Forchap, et al.
BMC Research Notes|November 19, 2013
Delirium in acute promyelocytic leukemia patients: two case reportsGian Matteo Rigolin, Sara Martinelli, Luca Formigaro, et al.
Blood|January 28, 2006
Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL)Paola Secchiero, Elisa Barbarotto, Mario Tiribelli, et al.
Molecular Cancer|May 28, 2010
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemiaManuela Ferracin, Barbara Zagatti, Lara Rizzotto, et al.
British Journal of Haematology|March 22, 2003
Soluble urokinase-type plasminogen activator receptor (suPAR) as an independent factor predicting worse prognosis and extra-bone marrow involvement in multiple myeloma patientsGian Matteo Rigolin, Alessia Tieghi, Maria Ciccone, et al.
Leukemia Research|July 27, 2014
Appropriate use of bendamustine in first-line therapy of chronic lymphocytic leukemia. Recommendations from SIE, SIES, GITMO GroupAntonio Cuneo, Monia Marchetti, Giovanni Barosi, et al.
Oncotarget|January 15, 2015
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemiasEmmanouil Athanasakis, Elisabetta Melloni, Gian Matteo Rigolin, et al.
Leukemia Research|September 3, 2011
SIE, SIES, GITMO updated clinical recommendations for the management of chronic lymphocytic leukemiaFrancesca Romana Mauro, Giuseppe Bandini, Giovanni Barosi, et al.
British Journal of Haematology|August 4, 2004
In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34 cellsGian Matteo Rigolin, Matteo Della Porta, Maria Ciccone, et al.
Plos One|September 9, 2016
The Active Metabolite of Warfarin (3'-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics StudyDonato Gemmati, Francesco Burini, Anna Talarico, et al.
Pageof 19